ciprofloxacin has been researched along with Adverse Drug Event in 24 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoroquinolones reduce occurrence of fever in adult cancer patients who develop neutropenia, but there has been no randomized controlled trial in children, and there are only a few studies considering resistance in intestinal floral after ciprofloxacin has been used." | 9.17 | Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. ( Chelae, S; Khwanna, T; Laoprasopwattana, K; Sujjanunt, T; Suwankeeree, P; Tunyapanit, W, 2013) |
| " We present a 56-year-old man with a history of hypertension, chronic kidney disease stage IIIa, recent exposure to ciprofloxacin who presented with acute kidney injury." | 8.02 | Atypical presentation of allergic interstitial nephritis likely induced by ciprofloxacin. ( Jim, B; Saad, P; Sekulic, M; Valdez Imbert, R, 2021) |
| "Ciprofloxacin (CIPRO) is a fluroquinolone class antibiotic used commonly for the treatment of various acute and chronic bacterial infections." | 6.72 | Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies. ( Chhabra, M; Kashyap, A; Rajan, AK; Rashid, M; Sreenivasan, S, 2021) |
| "This report describes a new observation of hyperglycemia in a child with Type 1 diabetes after off-label use of otic ciprofloxacin/dexamethasone drops in the nasal passage and reviews previous reports of adverse endocrine effects from intranasal corticosteroids in pediatric patients." | 5.41 | Off-Label Use of Ciprofloxacin/Dexamethasone Drops in the Pediatric Upper Airway: Case Presentation and Review of Adverse Effects. ( April, MM; Ben-Dov, T; Yang, J, 2023) |
| "Fluoroquinolones reduce occurrence of fever in adult cancer patients who develop neutropenia, but there has been no randomized controlled trial in children, and there are only a few studies considering resistance in intestinal floral after ciprofloxacin has been used." | 5.17 | Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. ( Chelae, S; Khwanna, T; Laoprasopwattana, K; Sujjanunt, T; Suwankeeree, P; Tunyapanit, W, 2013) |
| " We present a 56-year-old man with a history of hypertension, chronic kidney disease stage IIIa, recent exposure to ciprofloxacin who presented with acute kidney injury." | 4.02 | Atypical presentation of allergic interstitial nephritis likely induced by ciprofloxacin. ( Jim, B; Saad, P; Sekulic, M; Valdez Imbert, R, 2021) |
| "Based on 1422 cases of fluoroquinolone-associated hypersensitivity reactions and national drug utilization projections, we estimated risk of hypersensitivity reactions for moxifloxacin, ciprofloxacin, and levofloxacin." | 3.79 | US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions. ( Budnitz, DS; Jones, SC; Mehta, H; Sorbello, A, 2013) |
| "Ciprofloxacin (CIPRO) is a fluroquinolone class antibiotic used commonly for the treatment of various acute and chronic bacterial infections." | 2.72 | Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies. ( Chhabra, M; Kashyap, A; Rajan, AK; Rashid, M; Sreenivasan, S, 2021) |
| "Potential drug-drug interactions (pDDIs) are described in various case reports, but few studies have evaluated the impact of specific combinations on a population level." | 1.48 | Analysis of Drug-Drug Interactions in Swiss Claims Data Using Tizanidine and Ciprofloxacin as a Prototypical Contraindicated Combination. ( Curkovic, I; Egbring, M; Jödicke, AM; Kullak-Ublick, GA; Neuer, T; Roos, M; Tomka, IT; Zellweger, U, 2018) |
| " We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts." | 1.37 | FDA-approved drug labeling for the study of drug-induced liver injury. ( Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011) |
| "5 million adverse drug reaction (ADR) reports for 8620 drugs/biologics that are listed for 1191 Coding Symbols for Thesaurus of Adverse Reaction (COSTAR) terms of adverse effects." | 1.32 | Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. ( Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL, 2004) |
| " A few selected examples of potential drug-drug interactions and interventions instituted are presented in this paper." | 1.29 | Preventing potential drug interactions in community pharmacy. ( Lien, EJ; Lien, LL, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 6 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matthews, EJ | 1 |
| Kruhlak, NL | 1 |
| Weaver, JL | 1 |
| Benz, RD | 1 |
| Contrera, JF | 1 |
| Mohamed, MS | 1 |
| Kamel, MM | 1 |
| Kassem, EM | 1 |
| Abotaleb, N | 1 |
| Abd El-Moez, SI | 1 |
| Ahmed, MF | 1 |
| Chen, M | 1 |
| Vijay, V | 1 |
| Shi, Q | 2 |
| Liu, Z | 2 |
| Fang, H | 2 |
| Tong, W | 2 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Sakatis, MZ | 1 |
| Reese, MJ | 1 |
| Harrell, AW | 1 |
| Taylor, MA | 1 |
| Baines, IA | 1 |
| Chen, L | 1 |
| Bloomer, JC | 1 |
| Yang, EY | 1 |
| Ellens, HM | 1 |
| Ambroso, JL | 1 |
| Lovatt, CA | 1 |
| Ayrton, AD | 1 |
| Clarke, SE | 1 |
| Morgan, RE | 1 |
| van Staden, CJ | 1 |
| Chen, Y | 1 |
| Kalyanaraman, N | 1 |
| Kalanzi, J | 1 |
| Dunn, RT | 1 |
| Afshari, CA | 1 |
| Hamadeh, HK | 1 |
| Ben-Dov, T | 1 |
| Yang, J | 1 |
| April, MM | 1 |
| Hartinger, JM | 1 |
| Dvorackova, E | 1 |
| Myslivecek, M | 1 |
| Hruskova, Z | 1 |
| Satny, M | 1 |
| Zlatohlavek, L | 1 |
| Krizova, J | 1 |
| Sima, M | 1 |
| Tesar, V | 1 |
| Slanar, O | 1 |
| Kashyap, A | 1 |
| Sreenivasan, S | 1 |
| Rajan, AK | 1 |
| Rashid, M | 1 |
| Chhabra, M | 1 |
| Valdez Imbert, R | 1 |
| Sekulic, M | 1 |
| Saad, P | 1 |
| Jim, B | 1 |
| Rabbi, F | 1 |
| Qayum, I | 1 |
| Humayun, O | 1 |
| Khan, MI | 1 |
| Khan, UI | 1 |
| Abdullah, HMA | 1 |
| Huruba, M | 1 |
| Farcas, A | 1 |
| Leucuta, DC | 1 |
| Bucsa, C | 1 |
| Sipos, M | 1 |
| Mogosan, C | 1 |
| Jödicke, AM | 1 |
| Curkovic, I | 1 |
| Zellweger, U | 1 |
| Tomka, IT | 1 |
| Neuer, T | 1 |
| Kullak-Ublick, GA | 1 |
| Roos, M | 1 |
| Egbring, M | 1 |
| Mollica, AJ | 2 |
| Grant, E | 1 |
| Malik, A | 1 |
| Claydon, M | 1 |
| Friedman, ND | 1 |
| Athan, E | 1 |
| Hughes, AJ | 1 |
| Khajehnoori, M | 1 |
| McDonald, A | 1 |
| Callan, P | 1 |
| Rahdon, R | 1 |
| O'Brien, DP | 1 |
| Jones, SC | 1 |
| Budnitz, DS | 1 |
| Sorbello, A | 1 |
| Mehta, H | 1 |
| Hawke, KL | 1 |
| McGuire, TM | 1 |
| Ranmuthugala, G | 1 |
| van Driel, ML | 1 |
| Garbe, E | 1 |
| Andersohn, F | 1 |
| Bronder, E | 1 |
| Klimpel, A | 1 |
| Thomae, M | 1 |
| Schrezenmeier, H | 1 |
| Hildebrandt, M | 1 |
| Späth-Schwalbe, E | 1 |
| Grüneisen, A | 1 |
| Mayer, B | 1 |
| Salama, A | 1 |
| Kurtal, H | 1 |
| Laoprasopwattana, K | 1 |
| Khwanna, T | 1 |
| Suwankeeree, P | 1 |
| Sujjanunt, T | 1 |
| Tunyapanit, W | 1 |
| Chelae, S | 1 |
| Preskorn, SH | 1 |
| Lien, LL | 1 |
| Lien, EJ | 1 |
| Bernstein, RM | 1 |
| García Porrúa, C | 1 |
| González Gay, MA | 1 |
| Rivas, MJ | 1 |
| Ramos Gudino, B | 1 |
| Vogel, CU | 1 |
| Peiter, A | 1 |
| Feuring, M | 1 |
| Wehling, M | 1 |
3 reviews available for ciprofloxacin and Adverse Drug Event
| Article | Year |
|---|---|
Off-Label Use of Ciprofloxacin/Dexamethasone Drops in the Pediatric Upper Airway: Case Presentation and Review of Adverse Effects.
Topics: Administration, Intranasal; Blood Glucose; Child; Ciprofloxacin; Dexamethasone; Diabetes Mellitus, T | 2023 |
Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Eruptions; Drug-Related Side Effects and Adverse Reaction | 2021 |
Drugs and toxins: fact and fancy.
Topics: Anti-Infective Agents; Ciprofloxacin; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; | 1999 |
1 trial available for ciprofloxacin and Adverse Drug Event
| Article | Year |
|---|---|
Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agen | 2013 |
20 other studies available for ciprofloxacin and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Dru | 2004 |
Novel 6,8-dibromo-4(3H)quinazolinone derivatives of anti-bacterial and anti-fungal activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Drug Design; Drug-Related Side Effects and Adver | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Des | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
The frequency of, and predisposing risk factors for, ciprofloxacin-induced neuro-psychiatric adverse drug reactions.
Topics: Aged; Ciprofloxacin; Disease Susceptibility; Drug-Related Side Effects and Adverse Reactions; Humans | 2023 |
Atypical presentation of allergic interstitial nephritis likely induced by ciprofloxacin.
Topics: Acute Kidney Injury; Ciprofloxacin; Drug-Related Side Effects and Adverse Reactions; Humans; Male; M | 2021 |
Ciprofloxacin-Associated Pancytopenia: A Rare Side Effect of a Commonly Prescribed Medication.
Topics: Ciprofloxacin; Drug-Related Side Effects and Adverse Reactions; Humans; Iatrogenic Disease; Pancytop | 2023 |
A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Adverse Drug Reaction Reporting Systems; Arthralgia; Cip | 2021 |
Analysis of Drug-Drug Interactions in Swiss Claims Data Using Tizanidine and Ciprofloxacin as a Prototypical Contraindicated Combination.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Clonidine; Cohort | 2018 |
Ciprofloxacin-Induced Bullae of the Lower Extremity: A Case of a Fixed Drug Reaction.
Topics: Anti-Bacterial Agents; Blister; Ciprofloxacin; Drug-Related Side Effects and Adverse Reactions; Foot | 2019 |
Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Australia; Buruli Ulcer; Ciprofloxacin; Cl | 2013 |
US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions.
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Drug-Related Side Effects and Adve | 2013 |
What do consumers want to know about antibiotics? Analysis of a medicines call centre database.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Australia; Child; Child, Preschool; Cip | 2016 |
Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; An | 2011 |
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin; | 2008 |
Preventing potential drug interactions in community pharmacy.
Topics: Chelating Agents; Ciprofloxacin; Drug Interactions; Drug Therapy; Drug-Related Side Effects and Adve | 1994 |
[Cutaneous vasculitis and drugs].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug-Related Side Effects and Adverse Reactions; Female; Human | 2001 |
[Drug therapy in the old age. Drug effects in the elderly].
Topics: Age Factors; Aged; Aged, 80 and over; Algorithms; Anti-Infective Agents; Anti-Infective Agents, Urin | 2001 |